OBJECTIVES: To study the clinical features and fibroblast growth factor receptor 3 (FGFR3) gene mutations of children with achondroplasia (ACH) through an analysis of 17 cases. METHODS: A retrospective analysis was performed on the clinical data and FGFR3 gene detection results of 17 children with ACH who were diagnosed from January 2009 to October 2021. RESULTS: Of the 17 children with ACH, common clinical manifestations included disproportionate short stature (100%, 17/17), macrocephaly (100%, 17/17), trident hand (82%, 14/17), and genu varum (88%, 15/17). The common imaging findings were rhizomelic shortening of the long bones (100%, 17/17) and narrowing of the lumbar intervertebral space (88%, 15/17). Major complications included skeletal dysplasia (100%, 17/17), middle ear dysfunction (82%, 14/17), motor/language developmental delay (88%, 15/17), chronic pain (59%, 10/17), sleep apnea (53%, 9/17), obesity (41%, 7/17), foramen magnum stenosis (35%, 6/17), and hydrocephalus (24%, 4/17). All 17 children (100%) had FGFR3 mutations, among whom 13 had c.1138G>A hotspot mutations of the FGFR3 gene, 2 had c.1138G>C mutations of the FGFR3 gene, and 2 had unreported mutations, with c.1252C>T mutations of the FGFR3 gene in one child and c.445+2_445+5delTAGG mutations of the FGFR3 gene in the other child. CONCLUSIONS: This study identifies the unreported mutation sites of the FGFR3 gene, which extends the gene mutation spectrum of ACH. ACH is a progressive disease requiring lifelong management through multidisciplinary collaboration.
OBJECTIVES: To study the clinical features and fibroblast growth factor receptor 3 (FGFR3) gene mutations of children with achondroplasia (ACH) through an analysis of 17 cases. METHODS: A retrospective analysis was performed on the clinical data and FGFR3 gene detection results of 17 children with ACH who were diagnosed from January 2009 to October 2021. RESULTS: Of the 17 children with ACH, common clinical manifestations included disproportionate short stature (100%, 17/17), macrocephaly (100%, 17/17), trident hand (82%, 14/17), and genu varum (88%, 15/17). The common imaging findings were rhizomelic shortening of the long bones (100%, 17/17) and narrowing of the lumbar intervertebral space (88%, 15/17). Major complications included skeletal dysplasia (100%, 17/17), middle ear dysfunction (82%, 14/17), motor/language developmental delay (88%, 15/17), chronic pain (59%, 10/17), sleep apnea (53%, 9/17), obesity (41%, 7/17), foramen magnum stenosis (35%, 6/17), and hydrocephalus (24%, 4/17). All 17 children (100%) had FGFR3 mutations, among whom 13 had c.1138G>A hotspot mutations of the FGFR3 gene, 2 had c.1138G>C mutations of the FGFR3 gene, and 2 had unreported mutations, with c.1252C>T mutations of the FGFR3 gene in one child and c.445+2_445+5delTAGG mutations of the FGFR3 gene in the other child. CONCLUSIONS: This study identifies the unreported mutation sites of the FGFR3 gene, which extends the gene mutation spectrum of ACH. ACH is a progressive disease requiring lifelong management through multidisciplinary collaboration.
Authors: David Tunkel; Yewande Alade; Richard Kerbavaz; Beth Smith; Danielle Rose-Hardison; Julie Hoover-Fong Journal: Am J Med Genet A Date: 2012-05-24 Impact factor: 2.802
Authors: Alessio Coi; Michele Santoro; Ester Garne; Anna Pierini; Marie-Claude Addor; Jean-Luc Alessandri; Jorieke E H Bergman; Fabrizio Bianchi; Ljubica Boban; Paula Braz; Clara Cavero-Carbonell; Miriam Gatt; Martin Haeusler; Kari Klungsøyr; Jennifer J Kurinczuk; Monica Lanzoni; Nathalie Lelong; Karen Luyt; Olatz Mokoroa; Carmel Mullaney; Vera Nelen; Amanda J Neville; Mary T O'Mahony; Isabelle Perthus; Judith Rankin; Anke Rissmann; Florence Rouget; Bruno Schaub; David Tucker; Diana Wellesley; Katarzyna Wisniewska; Nataliia Zymak-Zakutnia; Ingeborg Barišić Journal: Am J Med Genet A Date: 2019-07-11 Impact factor: 2.802
Authors: Julie Hoover-Fong; Moira S Cheung; Virginia Fano; Lars Hagenas; Jacqueline T Hecht; Penny Ireland; Melita Irving; Klaus Mohnike; Amaka C Offiah; Ericka Okenfuss; Keiichi Ozono; Cathleen Raggio; Louise Tofts; Dominique Kelly; Renée Shediac; Wayne Pan; Ravi Savarirayan Journal: Bone Date: 2021-02-03 Impact factor: 4.398
Authors: Nitasha Dhiman; Alia Albaghdadi; Cheryl K Zogg; Meesha Sharma; Julie E Hoover-Fong; Michael C Ain; Adil H Haider Journal: Qual Life Res Date: 2016-11-19 Impact factor: 4.147
Authors: Svein O Fredwall; Unni Steen; Olga de Vries; Cecilie F Rustad; Heidi Beate Eggesbø; Harald Weedon-Fekjær; Ingeborg B Lidal; Ravi Savarirayan; Grethe Månum Journal: Orphanet J Rare Dis Date: 2020-05-25 Impact factor: 4.123